| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/17/2004 | CN1142276C Pronucleus enhancer sample sequence and its application |
| 03/17/2004 | CN1142274C Polypeptide having cell withering promoting activity |
| 03/17/2004 | CN1142269C Glucosyltransferase excessive expression strain of streptococcus mutans and its construction process |
| 03/17/2004 | CN1142268C Bacillus firmus and its application |
| 03/17/2004 | CN1142267C Wall-breaking method for yeast cell |
| 03/17/2004 | CN1142266C Cr-enriched yeast containing high biomass and its preparing process |
| 03/17/2004 | CN1142265C Bacterial strain resisting selenium and preparing process thereof,and application in preparing medicine of preventing and treating arsenism |
| 03/17/2004 | CA2441462A1 Novel recombinant xylanases derived from anaerobic fungi, and the relevant sequences, expression vectors and hosts |
| 03/16/2004 | US6708120 Computer readable memory; analyzing interaction with rotamers; ranking by dead-end elimination (dee) computation |
| 03/16/2004 | US6706941 Absorbent article for controlling normal flora of the skin |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706525 Highly transformable bacterial cells and methods for producing the same |
| 03/16/2004 | US6706516 Engineering of metabolic control |
| 03/16/2004 | US6706510 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706505 Human E3α ubiquitin ligase family |
| 03/16/2004 | US6706503 Generating preferential microorganisms; obtain microorganism containing mutant gene, express gene and evaluate microorganism mutation response |
| 03/16/2004 | US6706501 Isolated nucleic acid molecule comprising selected nucleic acid sequence, encoding protein having 10,12-linoleate isomerase activity |
| 03/16/2004 | US6706496 Method for expression of heterologous proteins in yeast |
| 03/16/2004 | US6706495 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 03/16/2004 | US6706492 Multiply transformed koji mold and a method of manufacturing a flavor enhancer using the same |
| 03/16/2004 | US6706278 Pigment- containing materials to be added to feeds |
| 03/16/2004 | CA2122837C Method for refolding igf-1 to active conformation |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020643A2 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 03/11/2004 | WO2004020640A2 Zinc-regulated prokaryotic expression cassettes |
| 03/11/2004 | WO2004020639A2 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | WO2004020638A1 Process for producing glucose dehydrogenases |
| 03/11/2004 | WO2004020621A1 Thermostable ribonuclease h |
| 03/11/2004 | WO2004020612A1 Methods for producing mammalian trypsins |
| 03/11/2004 | WO2004020611A1 Myrothecium sp. transformation and expression system |
| 03/11/2004 | WO2004020598A2 Abiz phage resistance gene |
| 03/11/2004 | WO2004020406A2 Variants of vibrio cholerae o1 biotype e1 tor with attributes of classical biotype |
| 03/11/2004 | WO2004019977A2 Improved bacterial outer membrane vesicles |
| 03/11/2004 | WO2004019879A2 Motilide compounds |
| 03/11/2004 | WO2004019878A2 Adzymes and uses thereof |
| 03/11/2004 | WO2004003231A3 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 03/11/2004 | WO2003097873A3 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications |
| 03/11/2004 | WO2003095480A3 Brachyspira hyodysenteriae vaccine |
| 03/11/2004 | WO2003091396A3 Polypeptides and biosynthetic pathways |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003077642A3 Population of transgenic plants, biological material derived therefrom, corresponding plasmid collection and population of transformed host organisms, use thereof and methods for producing the same |
| 03/11/2004 | WO2003055974A3 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 03/11/2004 | WO2003046183A3 Streptococcus suis avirulent vaccine and uses in antibiotic design |
| 03/11/2004 | WO2003035878A3 Lipase variants |
| 03/11/2004 | WO2003025116A3 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003018771A3 A system for antibody expression and assembly |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003012393A3 Method of detecting protease activity in a cell |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2002101026A8 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049230 Biomimetic membranes |
| 03/11/2004 | US20040049062 High triglyceride content and high oxidative stability. |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040049010 Transmembrane proteins |
| 03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
| 03/11/2004 | US20040048778 Selective growth media |
| 03/11/2004 | US20040048355 Process for the isolation and acclimatization of bacteria for lignin degradation |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048351 Alpha-amylase mutants |
| 03/11/2004 | US20040048343 Method and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048326 Comprises chromogenic or fluorogenic substrates that react with esterases specific for target strains; improved translucence, stability; detecting salmonellae |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048309 DNA from thermophilic bacterium; chromosomal replicases |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048293 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 03/11/2004 | US20040048290 Aminoacyl trna synthetases |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047868 Administering probiotic, wherein the probiotic is probiotic bacteria selected from Lactobacillus species, with the proviso that the Lactobacillus species is not Lactobacillus GG for prophylaxis and therapy of endotoxemia |
| 03/11/2004 | US20040047850 Bifidobacteria and preparations containing them |
| 03/11/2004 | US20040047849 Method for treating allergy in a subject comprising administrating said subject with a medicament comprising a lactic acid bacterial strain stimulating INF- gamma secretion, which is selected from the group consisting of Lactobacillus |
| 03/11/2004 | US20040047844 Methods and processes of inactivating viral contaminants in a biological source material (e.g. a host cell, cell supernatant, cell lysate, blood plasma, tissue homogenate, or other biological materials) with a solution containing |
| 03/11/2004 | US20040047842 Monascus purpureus mutants and their use in preparing fermentation products having blood pressure lowering activity |
| 03/11/2004 | US20040047840 Control agents |
| 03/11/2004 | DE10240603A1 Verwendung von Malat-Dehydrogenase zur NADH-Regenerierung Use of malate dehydrogenase for NADH regeneration |
| 03/11/2004 | CA2497165A1 Improved bacterial outer membrane vesicles |
| 03/11/2004 | CA2497047A1 Adzymes and uses thereof |
| 03/11/2004 | CA2496885A1 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | CA2496630A1 Abiz phage resistance gene |
| 03/11/2004 | CA2496350A1 Zinc-regulated prokaryotic expression cassettes |
| 03/11/2004 | CA2494981A1 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/10/2004 | EP1396546A2 mycobacteria functional screening and/or expression vectors |
| 03/10/2004 | EP1396543A2 Primers for synthesizing full length cDNA clones and their use |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396500A1 Anti-trail-r antibodies |
| 03/10/2004 | EP1396271A1 Use of germination-activated ganoderma lucidium spores as anti-aging agent and against menopause symptoms |